Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2).
about
The Use of Rat and Mouse Models in Bariatric Surgery ExperimentsEffects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgeryMetabolic Surgery for Type 2 Diabetes Mellitus: Experience from AsiaDiabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.Cardiovascular benefits of bariatric surgery in morbidly obese patients.Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American SocGastric band is safe and effective at three years in a national study subgroup of non-morbidly obese patientsBeyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery.Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus.Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus.Mechanisms underlying weight loss and metabolic improvements in rodent models of bariatric surgery.Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass.Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2)Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.Resolution of Uncontrolled Type 2 Diabetes after Laparoscopic Truncal Vagotomy, Subtotal Gastrectomy, and Roux-en-Y Gastrojejunostomy for a Patient with Intractable Gastric Ulcers.Cure of type 2 diabetes by metabolic surgery? A critical analysis of the evidence in 2010.Bariatric surgery - can we afford to do it or deny doing it?Oxalate nephropathy: An important cause of renal failure after bariatric surgery.Bariatric surgeries: beyond restriction and malabsorption.Diabetic and bariatric surgery: a review of the recent trends.Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2.Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m(2): A Surgeon's Perspective.Role of metabolic surgery in less obese or non-obese subjects with type 2 diabetes: influence over cardiovascular events.Efficacy of metabolic surgery on HbA1c decrease in type 2 diabetes mellitus patients with BMI <35 kg/m2--a review.Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).Lipidomic profiling at the interface of metabolic surgery and cardiovascular disease.Gap Between Evidence and Patient Access: Policy Implications for Bariatric and Metabolic Surgery in the Treatment of Obesity and its Complications.Changing Guidelines for Metabolic Surgery: Now It's the Time!Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes.High rates of diabetes reversal in newly diagnosed Asian Indian young adults with type 2 diabetes mellitus with intensive lifestyle therapy.Decreased Cardiovascular Risk after Roux-en-Y Gastric Bypass Surgery in Chinese Diabetic Patients with Obesity.The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index < 35 kg/m(2): preliminary results.Type 2 diabetes mellitus control and atherosclerosis prevention in a non-obese rat model using duodenal-jejunal bypass.Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner.Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients.Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB.The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement.Early detection of changes in lung mechanics with oscillometry following bariatric surgery in severe obesity.Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study.
P2860
Q26740015-B33F6075-1F03-485E-AE45-E2BD3AFB2BEBQ26995145-6C97CBFF-9199-4AD1-AB44-76E4A997F7A6Q28069918-72ADEA72-4F2C-421E-A613-A6330DAD8D71Q30394286-D0DA9217-4FC0-48EA-A025-9A83C85A01D8Q33829180-A020B4E0-FEA3-45C7-B12A-763B2BDDE639Q34075016-3EFBB218-3F2F-4CA2-99F2-DEB0599C4C7FQ34147871-7D251956-22D0-4854-A8BE-3455C5DB8BA4Q34159784-D9452C87-40FD-4E2C-BC78-BDF75C4A9D2CQ34338711-A7AFFC17-2316-40E0-A849-44EFDFB8671AQ34366918-50997E69-1649-4E64-9FED-ECE4C5EBE2B3Q34898952-C866DA29-5CBD-4D52-BED5-9F86C13A5595Q35169232-7A4A3672-D8E4-4D51-B825-D026061643DCQ35232361-79682E66-0472-4CE9-8E91-8B297F79B0D8Q36031995-A9EA8664-7CD1-41A2-ABB9-7D43FA8A9ADDQ36047225-AAC8BFC4-A276-4967-A2BD-6CED30BFB674Q36415083-FCD7CAD9-ADA1-4136-8A47-C06B2B450B98Q36790184-99C40392-CE69-4732-BE90-1BD8F1A11C5AQ36963426-D4F41BCD-9F1E-480F-8367-256A25D243E7Q37091166-917B2542-0496-40FE-B96B-BAB54412FF52Q37930951-B6C30403-C076-4307-9478-63CFB26C2C5BQ37945106-89C20BED-84E5-434A-B808-5C6C028351B2Q37952437-7871C6CA-31AB-4253-8F6D-2B4511232FBBQ38096980-9FE898ED-5A7D-4BEC-B0D7-0F30A097C522Q38129778-869E05ED-0322-4E5C-B549-BA4F668CA920Q38163432-1D9ED61B-FAA5-4E4E-B963-5B5BE245961AQ38196736-F46F556C-D1B1-4ABC-89E7-1B1789B5A574Q38252517-FA0EF118-B935-4099-8511-F3BA43C7E9ACQ38524401-DA450AAE-1548-495E-A85D-D3AB62E78F7EQ38868419-113D68D6-0023-42FC-9506-74FF79382FECQ39256982-8ED36304-CA91-4674-8252-E4D377396E08Q40311926-F76F008C-CD0A-4363-860F-09B5A53C3D03Q41040405-8995D100-265A-4B45-86A0-360DD4A91202Q42105623-51C7A157-1785-467F-AF0D-F77207F5773CQ42753016-356647ED-5FC8-4979-8352-F3216D754BB1Q42873394-8A653E92-2FAA-4C5A-9193-EC13181E28D8Q45181497-0657F699-2387-4F05-9E81-7E4890161382Q46495843-73FFF73B-8D51-4502-B826-8F8695C256BBQ47847024-559941DE-8167-4D38-AE80-72A5A64123E6Q47864012-D0D7AE28-341D-48A4-8425-51F7BCB40F44Q50165895-A592C4B8-D335-4E00-A1B3-F16870EC92B7
P2860
Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2).
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Diabetes remission and reduced ...... h body mass index <35 kg/m(2).
@ast
Diabetes remission and reduced ...... h body mass index <35 kg/m(2).
@en
type
label
Diabetes remission and reduced ...... h body mass index <35 kg/m(2).
@ast
Diabetes remission and reduced ...... h body mass index <35 kg/m(2).
@en
prefLabel
Diabetes remission and reduced ...... h body mass index <35 kg/m(2).
@ast
Diabetes remission and reduced ...... h body mass index <35 kg/m(2).
@en
P2093
P2860
P1476
Diabetes remission and reduced ...... h body mass index <35 kg/m(2).
@en
P2093
David E Cummings
Jayashree S Todkar
Poonam S Shah
Shashank S Shah
P2860
P304
P356
10.1016/J.SOARD.2009.08.009
P577
2009-09-03T00:00:00Z